At the news
? NEUTRALIMPACT 3/10 S-3 filed Jun 25, 2026 at 16:11 ET
Q32 Bio filed an S-3 shelf registration to issue an unlimited amount of senior or subordinated debt securities. This is a routine preparatory filing that does not represent an immediate offering or dilution. The company's latest 10-Q confirms it has no product revenue, significant operating losses, and will require substantial additional capital to fund operations.
- Filed S-3 shelf registration for an unlimited aggregate principal amount of debt securities (senior and subordinated).
- Two indentures (senior and subordinated) are included but no specific terms, pricing, or offering size are provided.
- As of May 1, 2026, the company had 16,956,415 shares of common stock outstanding.
- The 10-Q (filed May 5, 2026) states the company has no products for sale, no product revenue, and expects to continue incurring significant operating losses.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access